HIGHLIGHTS
- who: Caroline Dix from the Upstate Medical University, United States have published the Article: C-reactive protein, immunothrombosis and venous thromboembolism, in the Journal: (JOURNAL)
- what: The studies show that there are clearly deficiencies in using clinical risk scores alone, and other ways to stratify VTE risk in patients are needed.
- future: Research is required to fully elucidate this complex interaction. It appears CRP is useful in predicting VTE in the context of COVID-19 with Ddimer further improving risk assessment however larger prospective studies are required to confirm the association. Although these . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.